These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9272766)

  • 21. Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB1 receptor antagonist, SR 141716.
    Vacca G; Serra S; Brunetti G; Carai MA; Gessa GL; Colombo G
    Eur J Pharmacol; 2002 Jun; 445(1-2):55-9. PubMed ID: 12065194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between the CB1 receptor agonist Delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited.
    Järbe TU; Andrzejewski ME; DiPatrizio NV
    Pharmacol Biochem Behav; 2002 Nov; 73(4):911-9. PubMed ID: 12213538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats.
    McLaughlin PJ; Winston K; Swezey L; Wisniecki A; Aberman J; Tardif DJ; Betz AJ; Ishiwari K; Makriyannis A; Salamone JD
    Behav Pharmacol; 2003 Dec; 14(8):583-8. PubMed ID: 14665975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.
    Aceto MD; Scates SM; Lowe JA; Martin BR
    Eur J Pharmacol; 1995 Aug; 282(1-3):R1-2. PubMed ID: 7498260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats.
    Serra S; Carai MA; Brunetti G; Gomez R; Melis S; Vacca G; Colombo G; Gessa GL
    Eur J Pharmacol; 2001 Nov; 430(2-3):369-71. PubMed ID: 11711056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats.
    Cohen C; Perrault G; Voltz C; Steinberg R; Soubrié P
    Behav Pharmacol; 2002 Sep; 13(5-6):451-63. PubMed ID: 12394421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats.
    Colombo G; Serra S; Brunetti G; Gomez R; Melis S; Vacca G; Carai MM; Gessa L
    Psychopharmacology (Berl); 2002 Jan; 159(2):181-7. PubMed ID: 11862347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration.
    Lallemand F; Soubrié PH; De Witte PH
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1317-23. PubMed ID: 11584151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic alcohol administration combined with repeated re-exposures and withdrawals.
    Lallemand F; Soubrié P; De Witte P
    Alcohol Alcohol; 2004; 39(6):486-92. PubMed ID: 15466898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice.
    Wang L; Liu J; Harvey-White J; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1393-8. PubMed ID: 12538878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.
    Navarro M; Chowen J; Rocío A Carrera M; del Arco I; Villanúa MA; Martin Y; Roberts AJ; Koob GF; de Fonseca FR
    Neuroreport; 1998 Oct; 9(15):3397-402. PubMed ID: 9855288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats.
    Cippitelli A; Bilbao A; Hansson AC; del Arco I; Sommer W; Heilig M; Massi M; Bermúdez-Silva FJ; Navarro M; Ciccocioppo R; de Fonseca FR;
    Eur J Neurosci; 2005 Apr; 21(8):2243-51. PubMed ID: 15869521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats.
    Arnold JC; Hunt GE; McGregor IS
    Life Sci; 2001 Nov; 70(1):97-108. PubMed ID: 11764010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis.
    Santucci V; Storme JJ; Soubrié P; Le Fur G
    Life Sci; 1996; 58(6):PL103-10. PubMed ID: 8569415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats.
    Serra S; Brunetti G; Pani M; Vacca G; Carai MA; Gessa GL; Colombo G
    Eur J Pharmacol; 2002 May; 443(1-3):95-7. PubMed ID: 12044797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
    Adams IB; Compton DR; Martin BR
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers.
    Rodríguez de Fonseca F; Roberts AJ; Bilbao A; Koob GF; Navarro M
    Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1109-14. PubMed ID: 11189201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine.
    Verty AN; Singh ME; McGregor IS; Mallet PE
    Psychopharmacology (Berl); 2003 Jul; 168(3):314-23. PubMed ID: 12700881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats.
    Lichtman AH; Martin BR
    Pharmacol Biochem Behav; 1997; 57(1-2):7-12. PubMed ID: 9164547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of rimonabant on behavior maintained by progressive ratio schedules of sucrose reinforcement in obese Zucker (fa/fa) rats.
    Rasmussen EB; Huskinson SL
    Behav Pharmacol; 2008 Oct; 19(7):735-42. PubMed ID: 18797250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.